ClinicalTrials.gov
ClinicalTrials.gov Menu

Dinutuximab in Combination With Sargramostim in Treating Patients With Recurrent Osteosarcoma

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT02484443
Recruitment Status : Suspended (Other - pending eval of pts currently enrolled on study)
First Posted : June 29, 2015
Last Update Posted : May 8, 2018
Sponsor:
Information provided by (Responsible Party):
National Cancer Institute (NCI)

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Suspended
  Estimated Primary Completion Date : December 31, 2018
  Estimated Study Completion Date : December 31, 2018